Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
127.7 USD | -0.44% | -2.68% | +17.12% |
05-02 | Merck: encouraging results in gastric cancer | CF |
05-01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.12% | 325B | |
+26.77% | 681B | |
+21.85% | 556B | |
-4.96% | 361B | |
+5.24% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-4.24% | 157B | |
+8.68% | 149B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Credit Suisse Starts Merck at Outperform With $120 PT, Notes High Near-Term Growth, Low-Risk Ideal Against Uncertain Backdrop